Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $90.0000 (-10%) ($90.0000 - $100.5000) on Wed. Jun. 6, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.9% (three month average) | RSI | 34 | Latest Price | $90.0000(-10%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -2% a day on average for past five trading days. | Weekly Trend | CAPR declines -9.3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -3.95% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.95% (StdDev 7.9%) | Hourly BBV | 0 () | Intraday Trend | -10.4% | | | |
|
1 - 5 Day Possible Target | $79.21(-11.99%) | Resistance Level | $107.87 | 5 Day Moving Average | $98(-8.16%) | 10 Day Moving Average | $98.95(-9.04%) | 20 Day Moving Average | $107.87(-16.57%) | To recent high | -69% | To recent low | 0% | Market Cap | $1.773b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |